MS ISO 15189:2022 is an internationally recognized clinical standard that sets rigorous requirements for quality and competence in medical laboratories. Unlike targeted genetic panels, WGS examines a patient's complete DNA sequence, making accreditation at this level a meaningful technical distinction. The expanded accreditation confirms that MyGenome's genomic data meets the accuracy, reproducibility, and reliability benchmarks required for clinical use, healthcare adoption, and integration into research programs, positioning MyGenome among a select group of genomics laboratories in Southeast Asia operating WGS under this standard.